Show Notes
Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with Dr. Jonathan Meyer at the 2025 APA Conference. Dr. Meyer joins us at the beginning to provide an addendum to the original episode.
More from PsychRounds: The Psychiatry Podcast
Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.
Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.
Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.
We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.
We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.